Diabetes Drug Avandia Restricted by FDA

Representing Orlando, Tampa, Miami and Nearby Areas of Florida

The Food & Drug Administration announced Thursday that it was placing tough new restrictions on the diabetes drug, Avandia, to allow it to remain on the market. There have been concerns about Avandia increasing the risk of heart attacks and strokes. The FDA concluded that there was significant evidence that the risk of heart attack and strokes outweighed the medicine’s benefits for most patients. In the U.S., patients will only be allowed to take Avandia as a last resort if other drugs aren’t effective in controlling their blood sugar.